Are you Dr. Haluska?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
750 Washington St
Nemc Box #836
Boston, MA 02111Phone+1 617-636-5000
Summary
- Dr. Frank Haluska, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
Perelman School of Medicine at the University of PennsylvaniaClass of 1989
Certifications & Licensure
MA State Medical License 1991 - 2025
Publications & Presentations
PubMed
- 9 citationsPhase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other Biomarkers.Suzanne George, Margaret von Mehren, Jonathan A Fletcher, Jichao Sun, Sen Zhang
Clinical Cancer Research. 2022-04-01 - 382 citationsPonatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trialJorge E. Cortes, Dong-Wook Kim, Javier Pinilla-Ibarz, Philipp le Coutre, Ronald Paquette
Blood. 2018-07-26 - 409 citationsBrigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II TrialDong Wan Kim, Marcello Tiseo, Myung-Ju Ahn, Karen L. Reckamp, Karin Holmskov Hansen
Journal of Clinical Oncology. 2017-05-05
Press Mentions
Anchiano Appoints Steve DiPalma as Chief Financial OfficerMay 5th, 2020
Anchiano Therapeutics to Present at the Ladenburg Thalmann Healthcare ConferenceSeptember 20th, 2019- Anchiano Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment ConferenceSeptember 3rd, 2019
- Join now to see all
